Sanjay Chanda

CIK 1571820 · Chief Development Officer · last filed 2026-03-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$563.2K

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$655.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANTX Chief Development Officer 118,823 $4.74 $563.2K -$13.3K 9 2026-03-23
Anacor Pharmaceuticals, Inc. (ANAC) Delisted SVP, Drug Development 34,039 $10.19 $346.9K -$642.5K 8 2015-03-04

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-02-05 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Grant (A) +5,020 $0 EDGAR
2014-12-22 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Exer (M) +19,073 $115.9K EDGAR
2014-12-01 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Mixed -$138.8K EDGAR
2014-09-12 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Mixed -$181.1K EDGAR
2014-02-10 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Grant (A) $0 EDGAR
2013-11-08 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Grant (A) $0 EDGAR
2013-04-16 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Grant (A) $0 EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.